Citation

83 FR 28002

Canonical document for this Federal Register citation.

Prospective Grant of Exclusive Patent Commercialization License: Streptococcus Pneumonia PSAA Peptide for Treatment of Sepsis and Infection Friday, June 15, 2018 83 FR 28002